Sayan Muhammet, Fattahov Mahir, Temirkaynak Fevzi Oguzhan, Koska Nazmiye, Artiran Bengisu, Aslan Muhammet Tarik, Ahmadova Gunel, Kurtoglu Aysegul, Akarsu Irmak, Kurul Ismail Cuneyt, Celik Ali
Department of Thoracic Surgery, Gazi University, 06560, Ankara, Turkey.
Updates Surg. 2025 May 14. doi: 10.1007/s13304-025-02232-y.
Although minimally invasive methods have become widespread, pulmonary resections due to lung cancer continue to be an important cause of postoperative morbidity. Herein, we have investigated the predicting efficacy of modified frailty index-5 (MFI-5) for postoperative complications in patients who underwent pulmonary resection by VATS for non-small cell lung cancer (NSCLC). We retrospectively reviewed the data of patients who underwent VATS lobectomy/segmentectomy for NSCLC. MFI-5 score was calculated according to hypertension, diabetes mellitus, chronic obstructive pulmonary disease, congestive heart failure, and functional independence status. Major postoperative complications were determined based on Clavien-Dindo classification. The predictive efficacy of MFI-5 score for major complications was tested by univariate and multivariate logistic regression analysis. A total of 336 patients were included in the study. The mean age was 65.6 ± 9.8 years. MFI-5 score was zero in 126 (37.5%) patients and positive in 210 patients. The major complication rate was 25.9%. Multivariate analysis showed that 2 and higher MFI-5 score significantly predicted the presence of postoperative major complications (p: 0.004, OR: 4.3, 1.58-12.5 95% CI). The MFI-5 score can significantly predict the presence of major postoperative complications, including 30-day mortality, in patients undergoing VATS pulmonary resection for NSCLC. Clinical registration 2024-324, approved by Gazi University Local Ethics Committee.
尽管微创方法已广泛应用,但肺癌导致的肺切除术仍是术后发病的重要原因。在此,我们研究了改良脆弱指数-5(MFI-5)对接受非小细胞肺癌(NSCLC)电视辅助胸腔镜手术(VATS)肺切除术患者术后并发症的预测效能。我们回顾性分析了接受VATS肺叶切除术/肺段切除术治疗NSCLC患者的数据。根据高血压、糖尿病、慢性阻塞性肺疾病、充血性心力衰竭和功能独立状态计算MFI-5评分。术后主要并发症根据Clavien-Dindo分类确定。通过单因素和多因素逻辑回归分析检验MFI-5评分对主要并发症的预测效能。本研究共纳入336例患者。平均年龄为65.6±9.8岁。126例(37.5%)患者的MFI-5评分为零,210例患者为阳性。主要并发症发生率为25.9%。多因素分析显示,MFI-5评分≥2可显著预测术后主要并发症的发生(p:0.004,OR:4.3,95%CI:1.58-12.5)。MFI-5评分可显著预测接受VATS肺切除术治疗NSCLC患者术后主要并发症的发生,包括30天死亡率。临床注册号2024-324,经加齐大学地方伦理委员会批准。